Human metapneumovirus
| Azacitidine | HMPV | Nucleoside analog DNA methyl transferase inhibitor | Preclinical | — | Viral RNA pol | |
| Emetine | HMPV | — | Preclinical | — | Human ribosome | |
| Ingavirin | HMPV | Unknown | Approved (other) | Russia | Unknown | |
| Itraconazole | HMPV | Antifungal; hedgehog signaling inhibitor | Preclinical | — | Unknown | |
| Lopinavir | HMPV | HIV protease inhibitor | Approved (other) | Japan | Unknown | |
| Monensin | HMPV | — | Preclinical | — | Unknown | |
| Nitazoxanide | HMPV | Pyruvate inhibitor | Preclinical | — | Human pyruvate synthase | |
| Obatoclax | HMPV | Bcl-2 family inhibitor | Preclinical | — | Human MCL1 | |
| Oritavancin | HMPV | Transglycosylation; transpeptidation and cell membrane interaction/disruption inhibitor | Preclinical | — | Unknown | |
| Remdesivir | HMPV | Viral RNA polymerase inhibitor | Approved (other) | Japan | Viral RNA pol |